SMTL ID : 6g46.1

Red kidney bean purple acid phosphatase in complex with 2-(Naphthalen-1-yl)thiazole-4-carboxylic acid

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.40 Å
Oligo State
homo-tetramer
Ligands
6 x NAG- FUC- NAG: alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)]2-acetamido-2-deoxy-beta-D-glucopyranose
3 x NAG- FUC: alpha-L-fucopyranose-(1-3)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
4 x ZN: ZINC ION(Non-covalent)
4 x FE: FE (III) ION(Non-covalent)
8 x SO4: SULFATE ION(Non-functional Binders)
7 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
2 x ELH: 2-naphthalen-1-yl-1,3-thiazole-4-carboxylic acid(Non-covalent)
7 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
3 x NA: SODIUM ION(Non-functional Binders)
1 x IPA: ISOPROPYL ALCOHOL(Non-functional Binders)
1 x GOL: GLYCEROL(Non-functional Binders)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Hussein, W.M. et al., Purple acid phosphatase inhibitors as leads for osteoporosis chemotherapeutics. Eur J Med Chem (2018)
Release Date
2018-09-26
Peptides
Fe(3+)-Zn(2+) purple acid phosphatase: ABCD
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B
C
D
D
C

Fe(3+)-Zn(2+) purple acid phosphatase

Related Entries With Identical Sequence

4dhl.1 | 4dhl.2 | 4dsy.1 | 4dsy.2 | 4dt2.1 | 4dt2.2 | 6hwr.1 | 6hwr.2 | 6of5.1 | 6of5.2 | 6of5.3 | 6vj7.1